{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:05:40Z","timestamp":1756512340721,"version":"3.44.0"},"reference-count":24,"publisher":"SMC Media","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>We present the case of a 25-year-old woman without medical history, presenting with acute respiratory failure needing mechanical ventilation. Aetiologic screening showed PVB19 primary infection and concomitant SLE flare-up. We discuss the causative interactions between PVB19 and SLE in the pathogenesis of the disease. Difficulty diagnosing inaugural SLE flare-up concomitant with PVB19 infection can lead to delayed diagnosis and treatment. Inversely, overtreating a SLE-mimicking PVB19 infection with immunosuppressive agents can be highly detrimental.<\/jats:p>","DOI":"10.12890\/2020_001729","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T09:52:37Z","timestamp":1621936357000},"source":"Crossref","is-referenced-by-count":2,"title":["Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature"],"prefix":"10.12890","volume":"7","author":[{"given":"Paul","family":"Chabert","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Kallel","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Cayenne General Hospital, Cayenne, French Guiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10397","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"10.12890\/2020_001729_ref1","doi-asserted-by":"crossref","unstructured":"<li>Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zer\u00f3n P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. <em>Medicine (Baltimore)<\/em> 2008;<strong>87<\/strong>(6):311\u2013318. <\/li>","DOI":"10.1097\/MD.0b013e31818ec711"},{"key":"10.12890\/2020_001729_ref2","doi-asserted-by":"crossref","unstructured":"<li>Cooray M, Manolakos JJ, Wright DS, Haider S, Patel A. Parvovirus infection mimicking systemic lupus erythematosus. <em>CMAJ<\/em> 2013;<strong>185<\/strong>(15):1342\u20131344. <\/li>","DOI":"10.1503\/cmaj.121565"},{"key":"10.12890\/2020_001729_ref3","doi-asserted-by":"crossref","unstructured":"<li>Georges E, Rihova Z, Cmejla R, Decleire PY, Langen C. Parvovirus B19 induced lupus-like syndrome with nephritis. <em>Acta Clin Belg<\/em> 2016;<strong>71<\/strong>(6):423\u2013425. <\/li>","DOI":"10.1080\/17843286.2015.1111673"},{"key":"10.12890\/2020_001729_ref4","unstructured":"<li>Soloninka CA, Anderson MJ, Laskin CA. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. <em>J Rheumatol<\/em> 1989;<strong>16<\/strong>(6):777\u2013781.<\/li>"},{"key":"10.12890\/2020_001729_ref5","doi-asserted-by":"crossref","unstructured":"<li>Cugler T, Carvalho LM de, Facincani I, Yamamoto AY, Silva GEB, Costa RS, et al. Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus. <em>Scand J Rheumatol<\/em> 2012;<strong>41<\/em>(1):79\u201381. <\/li>","DOI":"10.3109\/03009742.2011.617315"},{"key":"10.12890\/2020_001729_ref6","doi-asserted-by":"crossref","unstructured":"<li>Loizou S, Cazabon JK, Walport MJ, Tait D, So AK. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. <em>Arthritis Rheum<\/em> 1997;<strong>40<\/strong>(1):103\u2013108. <\/li>","DOI":"10.1002\/art.1780400115"},{"key":"10.12890\/2020_001729_ref7","doi-asserted-by":"crossref","unstructured":"<li>Valencia Pacheco G, Nakazawa Ueji YE, Rodr\u00edguez Dzul EA, Angulo Ram\u00edrez AV, L\u00f3pez Villanueva RF, Quintal Ortiz IG, et al. Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico. <em>Colomb Med<\/em> (Cali) 2017;<strong>48<\/strong>(3):105\u2013112.<\/li>","DOI":"10.25100\/cm.v48i3.2981"},{"key":"10.12890\/2020_001729_ref8","doi-asserted-by":"crossref","unstructured":"<li>Hession MT, Au SC, Gottlieb AB. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction? <em>J Rheumatol<\/em> 2010;<strong>37<\/strong>(11):2430\u20132432. <\/li>","DOI":"10.3899\/jrheum.100345"},{"key":"10.12890\/2020_001729_ref9","unstructured":"<li>Speyer I, Breedveld FC, Dijkmans BA. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. <em>Clin Exp Rheumatol<\/em> 1998;<strong>16<\/strong>(5):576\u2013578. <\/li>"},{"key":"10.12890\/2020_001729_ref10","doi-asserted-by":"crossref","unstructured":"<li>Bengtsson A. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. <em>Ann Rheum Dis<\/em> 2000;<strong>59<\/strong>(1):64\u20136. <\/li>","DOI":"10.1136\/ard.59.1.64"},{"key":"10.12890\/2020_001729_ref11","doi-asserted-by":"crossref","unstructured":"<li>Page C, Fran\u00e7ois C, Go\u00ebb V, Duverlie G. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. <em>J Clin Virol<\/em> 2015;<strong>72<\/strong>:69\u201374. <\/li>","DOI":"10.1016\/j.jcv.2015.09.007"},{"key":"10.12890\/2020_001729_ref12","doi-asserted-by":"crossref","unstructured":"<li>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. <em>Arthritis Rheum<\/em> 1997;<strong>40<\/strong>(9):1725. <\/li>","DOI":"10.1002\/art.1780400928"},{"key":"10.12890\/2020_001729_ref13","doi-asserted-by":"crossref","unstructured":"<li>Chen J, Zhang H, Chen P, Lin Q, Zhu X, Zhang L, et al. Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods. <em>Clin Rheumatol<\/em> 2015;<strong>34<\/strong>(4):691\u2013698. <\/li>","DOI":"10.1007\/s10067-015-2868-3"},{"key":"10.12890\/2020_001729_ref14","doi-asserted-by":"crossref","unstructured":"<li>Chen DY, Chen YM, Tzang BS, Lan JL, Hsu TC. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection. <em>PLoS One<\/em> 2014;<strong>9<\/strong>(12):e113889. <\/li>","DOI":"10.1371\/journal.pone.0113889"},{"key":"10.12890\/2020_001729_ref15","doi-asserted-by":"crossref","unstructured":"<li>Kishi S, Yamada S, Kishi F, Shibata E, Matsuura M, Nagai K, et al. Acute glomerulonephritis in an immunocompetent elderly woman after contact with a child who had been diagnosed as erythema infectiosum. <em>Intern Med<\/em> 2012;<strong>51<\/strong>(16):2197\u20132201. <\/li>","DOI":"10.2169\/internalmedicine.51.7919"},{"key":"10.12890\/2020_001729_ref16","doi-asserted-by":"crossref","unstructured":"<li>Waldman M, Kopp JB. Parvovirus B19 and the kidney. <em>Clin J Am Soc Nephrol<\/em> 2007;<strong>2<\/strong> Suppl 1:S47\u2013S56. <\/li>","DOI":"10.2215\/CJN.01060307"},{"key":"10.12890\/2020_001729_ref17","doi-asserted-by":"crossref","unstructured":"<li>Isa A, Lundqvist A, Lindblom A, Tolfvenstam T, Broliden K. Cytokine responses in acute and persistent human parvovirus B19 infection. <em>Clin Exp Immunol<\/em> 2007;<strong>147<\/strong>(3):419\u2013425. <\/li>","DOI":"10.1111\/j.1365-2249.2006.03286.x"},{"key":"10.12890\/2020_001729_ref18","doi-asserted-by":"crossref","unstructured":"<li>Park SJ, Kim JH, Ha TS, Shin JI. Association of parvovirus B19 infection with systemic lupus erythematosus: role of Th1 predominance. <em>J Rheumatol<\/em> 2011;<strong>38<\/strong>(6):1221. <\/li>","DOI":"10.3899\/jrheum.101332"},{"key":"10.12890\/2020_001729_ref19","doi-asserted-by":"crossref","unstructured":"<li>Tokano Y, Morimoto S, Kaneko H, Amano H, Nozawa K, Takasaki Y, et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)\u2014relation to Th1- and Th2-derived cytokines. <em>Clin Exp Immunol<\/em> 1999;<strong>116<\/strong>(1):169\u2013173. <\/li>","DOI":"10.1046\/j.1365-2249.1999.00862.x"},{"key":"10.12890\/2020_001729_ref20","doi-asserted-by":"crossref","unstructured":"<li>Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, Hsu TC. Increased cardiac injury in NZB\/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.<em> Mol Immunol<\/em> 2011;<strong>48<\/strong>(12\u201313):1518\u20131524. <\/li>","DOI":"10.1016\/j.molimm.2011.04.013"},{"key":"10.12890\/2020_001729_ref21","doi-asserted-by":"crossref","unstructured":"<li>Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A. Human parvovirus B19 infection and autoimmunity. <em>Autoimmun Rev<\/em> 2008;<strong>8<\/strong>(2):116\u2013120. <\/li>","DOI":"10.1016\/j.autrev.2008.07.005"},{"key":"10.12890\/2020_001729_ref22","doi-asserted-by":"crossref","unstructured":"<li>Thammasri K, Rauham\u00e4ki S, Wang L, Filippou A, Kivovich V, Marjom\u00e4ki V, et al. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. <em>PLoS One<\/em> 2013;<strong>8<\/strong>(6):e67179. <\/li>","DOI":"10.1371\/journal.pone.0067179"},{"key":"10.12890\/2020_001729_ref23","doi-asserted-by":"crossref","unstructured":"<li>Meyer O. Parvovirus B19 and autoimmune diseases. <em>Joint Bone Spine<\/em> 2003;<strong>70<\/strong>(1):6\u201311. <\/li>","DOI":"10.1016\/S1297-319X(02)00004-0"},{"key":"10.12890\/2020_001729_ref24","doi-asserted-by":"crossref","unstructured":"<li>Pavlovic M, Kats A, Cavallo M, Shoenfeld Y. Clinical and molecular evidence for association of SLE with parvovirus B19. <em>Lupus<\/em> 2010;<strong>19<\/strong>(7):783\u2013792. <\/li>","DOI":"10.1177\/0961203310365715"}],"container-title":["European Journal of Case Reports in Internal Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/1729\/2402","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/1729\/2403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/1729\/2403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T12:17:18Z","timestamp":1756469838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/view\/1729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.12890\/2020_001729","relation":{"has-manifestation":[{"id-type":"other","id":"1-65-1729-g2402","asserted-by":"subject"},{"id-type":"other","id":"1-65-1729-g2403","asserted-by":"subject"}],"is-part-of":[{"id-type":"other","id":"1-65","asserted-by":"subject"}]},"ISSN":["2284-2594"],"issn-type":[{"type":"electronic","value":"2284-2594"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"article-number":"31"}}